Glenmark Pharmaceuticals reports 24% jump in Q1 consolidated net profit

Glenmark Pharmaceuticals has reported results for first quarter ended June 30, 2016.

The company has registered 53.23% jump in its net profit at Rs 518.81 crore for the quarter as compared to Rs 338.57 crore for the same quarter in the previous year. Total income of the company increased by 36.50 % at Rs 1738.80 crore for quarter under review as compared to Rs 1273.85 crore for the quarter ended June 30, 2015.

On the consolidated basis, the company has reported 23.96% jump in its net profit after taxes, minority interest and share of profit of associates at Rs 226.78 crore for the quarter ended June 30, 2016 as compared to Rs 182.95 crore for the same quarter in the previous year. However, total Income of the company increased by 22.13% to Rs 2018.97 crore for quarter under review from Rs 1653.11 crore for the quarter ended June 30, 2015.